Financial News · Live Terminal

Page 361 of 868

Legacy Minerals Holdings Enters Farm-in Agreement With Aurelia Metals for New South Wales Project

Legacy Minerals Holdings (ASX:LGM) struck a binding earn-in and farm-in agreement with Aurelia Metals (ASX:AMI) unit Peak Gold Mines covering Legacy's Cobar project in New South Wales, according to a Tuesday filing with the Australian bourse.Under the first stage of the agreement, Aurelia can earn a 51% interest by funding AU$500,000 worth of exploration within two years. Under stage two, Aurelia is set to earn a further 39% interest by funding an additional AU$1.5 million of exploration within five years.Once the second stage is complete, Legacy Minerals will retain ongoing exposure to the project through either a 10% joint venture participating interest or a net smelter return royalty on gold and base metals, the company said.Shares of Legacy Minerals fell nearly 4% in recent Tuesday trade, while Aurelia Metals was about 3% lower.

ASX:AMIASX:LGM

Asia41d ago

Trek Metals Starts Geophysical Survey, Pre-Drilling Earthworks at Western Australia Project

Trek Metals (ASX:TKM) started geophysical surveying and pre-drilling earthworks at the Kuro manganese discovery, within its Christmas Creek project in Western Australia, according to a Tuesday filing with the Australian bourse.Moombarriga Geoscience is conducting induced polarization surveying while Atlas Geophysics is undertaking extensional ground gravity surveying, with co-funding from the Western Australian Government's Exploration Incentive Scheme, the filing said.Drilling will start within the month, with construction of access tracks and drill pads in progress, per the filing.Shares rose 1% in morning trade on Tuesday.

ASX:TKM

Asia41d ago

Formosa Pharmaceuticals' BYQLOVI Eye Drop Wins Taiwan Approval for Post-Surgery Pain Treatment

Taiwan's Ministry of Health and Welfare approved Formosa Pharmaceuticals' (TPE:6838) eye-drop BYQLOVI for post-surgery eye-pain treatment, according to a filing on Tuesday.The new drug, approved Tuesday, has a code of APP13007.

TPE:6838

Asia41d ago

DroneShield Receives AU$25 Million US Joint Interagency Task Force Counter-Drone Technologies Contract; Shares Up 5%

DroneShield (ASX:DRO) received a contract for the supply of mobile and fixed site counter-drone technologies supporting the mission of the US Department of War's Joint Interagency Task Force 401, according to a Tuesday Australian bourse filing.The contract has an initial value of AU$19.3 million, with an additional AU$5.6 million in options of the end-user over a five-year period, the filing said.The counter-drone technologies include hardware, subscriptions, warranties, and services. The contract also requires the company to purchase and install third-party interoperable solutions.Payments will be received for the initial value from second half of the year through the first half of 2027.DroneShield's shares jumped nearly 5% in recent trading on Tuesday.

ASX:DRO

Asia41d ago

Coca-Cola Plans Public Listing of Indian Bottling Unit in 2027

Global beverage giant, The Coca-Cola Company, plans to list Hindustan Coca-Cola Holdings, the parent company of the largest Coca-Cola bottler in India, Hindustan Coca-Cola Beverages, according to an official statement on Monday.The India listing will include the sale of a portion of the Coca-Cola Company's shareholding in Hindustan Coca-Cola Holdings.The company is working on a potential listing on the Bombay Stock Exchange and National Stock Exchange of India in 2027, subject to market conditions and applicable regulatory and other approvals.In 2025, Indian conglomerate Jubilant Bhartia Group purchased a 40% stake in Hindustan Coca-Cola Holdings."The Coca-Cola Company will stay invested in this important bottler and focus on growing our portfolio of global and local brands in India," said Sanket Ray, president, India and Southwest Asia and Emerging Large Markets Lead for The Coca-Cola Company.Hindustan Coca-Cola Beverages operates 14 bottling plants across 10 states in India and works with eight co-packers.

^BSENifty 50

Asia41d ago

Telix Pharmaceuticals Says Prostate Cancer Treatement Candidate Shows Acceptable Tolerability in Phase Three Trial

Telix Pharmaceuticals (ASX:TLX) said its lutetium radio antibody-drug conjugate candidate, TLX591-Tx, demonstrated acceptable tolerability across all standard-of-care combination groups in the ProstACT global phase three study, with no new safety signals, supporting the feasibility of TLX591-Tx in combination with standard-of-care in post-ARPI metastatic castration-resistant prostate cancer, according to a Tuesday statement.The primary endpoint was the safety and tolerability of TLX591-Tx in combination with standard-of-care, while secondary endpoints included pharmacokinetics and radiation dosimetry.The trial enrolled prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer patients previously treated with one androgen receptor pathway inhibitor. It consisted of TLX591-Tx, administered as two doses 14 days apart, in combination with standard-of-care, which includes abiraterone, enzalutamide, or docetaxel, in comparison with standard-of-care alone. 36 patients received both doses of TLX591-Tx per protocol.Treatment-emergent non-hematologic events were primarily fatigue, nausea, and dry mouth. Radiation exposure to key organs was below established safety limits. Lesion dosimetry confirmed uptake across tumor sites and across all cohorts, while pharmacokinetics demonstrated sustained activity at Day 15.The firm initiated the second part of the study, a randomized treatment expansion, where it obtained regulatory approvals. It is engaging with the US Food and Drug Administration (FDA) to discuss the data from the first part and seek an Investigational New Drug (IND) amendment to advance the second part in the US.

ASX:TLX

Asia41d ago

Air New Zealand Group Capacity Rises in April

Air New Zealand (NZE:AIR, ASX:AIZ) group capacity rose 2.4% year on year in April, according to a Tuesday filing with the Australian and New Zealand bourses.Long-haul available seat kilometers (ASKs) rose 0.3%, while domestic ASKs increased by 2.2%, per the filing.Short-haul international ASKs rose 6.9% year on year, supported by the addition of two new A321 aircraft.Group year-to-date underlying revenue per available seat kilometer rose 2.8% from the prior year.The airline carried 1.3 million passengers in April, up 2.2% from the previous year, while the passenger load factor rose to nearly 86%, up from around 84%, the filing added.The company's New Zealand shares were down 2% in recent Tuesday trade.

ASX:AIZNZE:AIR

Asia41d ago

Market Chatter: Japan, US to Jointly Invest $1 Billion in AI, Advanced Tech Under Genesis Mission

Japan and the United States will jointly invest $1 billion over five years in artificial intelligence and other advanced fields under the Trump administration's Genesis Mission, Nikkei Asia reported Monday.Launched in 2025, the Genesis Mission aims to build a new AI platform by integrating federal scientific databases and national laboratory supercomputers. The project accelerates scientific research by using AI-driven hypothesis testing and automated processes.Under the agreement, Japan will contribute $500 million to collaborate on priority areas including biotechnology, nuclear fusion, and quantum information science, while senior Japanese officials plan to visit the US in early June for a joint announcement with the Department of Energy, the newswire said.Major tech companies, including Microsoft, Google, and Nvidia, will also participate by supplying advanced AI models and expanding supercomputing capacity, the report added.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Nikkei 225

Asia41d ago

Viridis Mining Enters Nonbinding Letter of Intent With Solvay for Proposed Supply From Brazil Rare Earth Project

Viridis Mining and Minerals (ASX:VMM) entered into a nonbinding letter of intent with Solvay regarding the proposed supply of mixed rare earth carbonate (MREC) from its Colossus rare earth project in Brazil, according to a Tuesday Australian bourse filing.The letter includes proposed offtake arrangements and a technical package, the filing said. It also provides a structured pathway for the companies to progress development milestones required to accelerate development of the project and support commercial MREC production from Brazil by 2028.

ASX:VMM

Asia41d ago

Many Peaks Minerals Finds Gold-Linked Anomalies at Ivory Coast Project

Many Peaks Minerals (ASX:MPK) found anomalies associated with gold mineralization confirmed in previous drilling following gradient array induced polarization field surveys at the Odienné project in the Ivory Coast, according to a Tuesday filing with the Australian bourse.A planned 8,000-meter air-core drilling is designed to follow up on priority targets, with results expected between June and August, the filing said.Additionally, a third drill rig has been mobilized as exploration advances at the Ferké project, per the filing.Shares rose 1% in morning trade on Tuesday.

ASX:MPK

Asia41d ago

Collins Foods Expands German Footprint With Acquisition of Eight KFC Restaurants

Collins Foods (ASX:CKF) has acquired eight KFC outlets in Bavaria from JJ Restaurant, expanding its presence in a key German region, according to a Tuesday Australian bourse filing.The deal expands its German portfolio by around 50%, reinforcing its presence across three major states that together represent more than half of the country's population and economic output, per the filing.The newly acquired restaurants generate higher margins than the company's existing German locations, boosting overall regional profitability, and will be included in financial consolidation starting Monday, the filing added.

ASX:CKF

Asia41d ago

Green Cross Health Exits Medical Division in NZ$270 Million Deal With Tend Health

Green Cross Health (NZE:GXH) has entered into a conditional agreement to sell its medical division, The Doctors, to Tend Health for NZ$270 million, subject to adjustments for net debt and working capital, according to a Tuesday filing with the New Zealand bourse.The Doctors runs 65 clinics across New Zealand and provides primary care to more than 400,000 enrolled patients, making it the country's largest enrolment-based general practice network, per the filing.The transaction is subject to shareholder approval at a meeting scheduled for July, and if approved, is expected to close by the end of that month, the filing said.The proceeds may be allocated to enhancing the company's pharmacy operations or distributed to shareholders, the filing added.

NZE:GXH

Asia41d ago

Maruti Suzuki Posts Record May Sales on Robust Domestic Demand

Maruti Suzuki India's (NSE:MARUTI, BOM:532500) total sales rose to a record 242,688 units in May from 180,077 units a year earlier, marking its highest-ever monthly sales, according to a filing with the Indian stock exchanges on Monday.Domestic sales reached an all-time high of 200,774 units, up from 148,858 units in the corresponding month last year.Exports increased to 41,914 units from 31,219 units a year ago.

BOM:532500NSE:MARUTI

Asia41d ago

Axis Bank Invests Additional INR3.81 Billion in Axis Max Life Insurance Company

Axis Bank (NSE:AXISBANK, BOM:532215) has invested an additional 3.81 billion Indian rupees in the equity shares of Axis Max Life Insurance Company, according to a Monday filing to the Indian stock exchanges.Following the investment, the shareholding of the lender and its subsidiaries, Axis Securities Limited and Axis Capital, will increase to 19.99% from 19.02%.

BOM:532215NSE:AXISBANK

Asia41d ago

4DMedical Launches CLEAR Clinical Program to Target $3 Billion Pulmonary Embolism Market

4DMedical (ASX:4DX) launched CLEAR, a clinical evidence program designed to accelerate entry of its CT:VQ imaging technology into the acute pulmonary embolism market, targeting a $3 billion obtainable market in the US, according to a Tuesday Australian bourse filing.The company said the core CLEAR study, which stands for Contrast-free Lung Evaluation for Acute Risk in pulmonary embolism, is a multi-center, multinational, prospective, observational study putting CT:VQ head-to-head with computed tomography pulmonary angiography in patients with suspected pulmonary embolism, the filing added.4DMedical has entered into a clinical research agreement with Mass General Brigham-affiliated teaching hospitals as the lead site for CLEAR, it added.

ASX:4DX

Asia41d ago

Market Chatter: Kioxia Seeks to Regain NAND Edge Against Rivals Like Samsung

Kioxia (TYO:285A) is seeking to recover lost market share by commercializing a new technology ahead of its competitors such as Samsung Electronics (KRX:005930), Nikkei Asia reported Tuesday, citing the company's engineer.The plan comes as rising demand for data center memory extends to NAND flash chips, the report said.The company is set to hold its first investor strategy briefing in a year on Tuesday, where Kioxia is expected to outline its technology roadmap, according to Nikkei.While Kioxia's predecessor Toshiba, pioneered vertical stacking technology for NAND in 2007, the company has recently lagged behind rivals in layer counts-its main products still use 218 layers, compared to SK Hynix's (KRX:000660) 300-plus-layer chip unveiled in summer 2023, the publication said.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

KRX:000660KRX:005930TYO:285A

Asia41d ago

KITZ Closes 9.2 Billion Yen Acquisition of V TEX

KITZ (TYO:6498) has finalized the acquisition of all shares of V TEX, turning the industrial special valve and rupture disk manufacturer into a fully owned subsidiary, according to a Tokyo bourse filing on Monday.The transaction involved purchasing 886,400 shares for nearly 9.2 billion yen, with total costs including advisory fees reaching around 9.37 billion yen.Following the acquisition, an extraordinary general meeting of V TEX shareholders approved the appointment of new directors and corporate auditors, leading to a restructured management team that includes Kenji Kato as President & CEO.Several new appointees, such as part-time director Tomoya Maekawa and part-time corporate auditors Toshiyuki Murasawa and Kenichi Bessho, will concurrently hold positions at KITZ.V TEX will be consolidated into KITZ's financial statements starting from the second quarter of the fiscal year ending December, with any material impact on results to be disclosed later.

TYO:6498

Asia41d ago

Atlas Arteria Continues to Reject IFM Global's Takeover Proposal

Atlas Arteria (ASX:ALX) issued a supplementary target statement that continues to recommend the rejection of a takeover bid by IFM Global Infrastructure Fund, according to a Tuesday filing with the Australian bourse.Atlas Arteria said it still believes the unsolicited IFM offer is too low, opportunistic, and highly conditional.An earlier bidder's statement filed by IFM "attempted to attack" some aspects of an independent expert analysis that Atlas is relying on, but the experts' panel remains satisfied that its opinions on the proposed deal "continue to be appropriate," Atlas said.Even if the offer's price was increased to the proposed maximum consideration, it would still materially undervalue Atlas, the company said, adding that the bidder is in a position to be able to pay more.

ASX:ALX

Asia41d ago

giftee to Transition to Holding Company Structure with July 1 Technical Listing on Prime Market

giftee (TYO:4449) said the holding company to be established through a sole share transfer on July 1, has received approval for a technical listing on the Tokyo Stock Exchange's Prime Market.Under the restructuring plan, the company's existing shares are scheduled to be delisted on June 29, with shareholders receiving one ordinary share of the new holding company, giftee Group, for each share they currently hold, according to a Tokyo bourse filing on Monday.The newly formed holding company will begin trading on July 1, under the securities code 590A, with a trading unit of 100 shares.

TYO:4449

Asia41d ago

Advertising Spending in Australia Falls in April, Jefferies Says

Advertising spending in Australia fell nearly 12% year on year to AU$634 million in April based on Standard Media Index data, compared with the same period last year, when ad spend was boosted by the federal election, Jefferies said in a Monday note.The market decline was 5.5% year on year, excluding the impact of the federal election.Outdoor advertising proved to be the "most defensive" ad category, with underlying figures up 0.8% year on year, as billboard and street furniture segments grow.The positive outdoor trend should alleviate concerns about the outlook for Nine Entertainment Co.'s (ASX:NEC) recently acquired billboard business, QMS, which is expected to hit double-digit growth in the fourth quarter of the year, Jefferies said.Additionally, there were reports suggesting Foxtel may partner with Seven or Ten to bid for the National Rugby League broadcasting rights, but Jefferies believes it is unlikely, with Seven broadcasting the Australian Football League and Ten facing financial pressure.

ASX:NEC

Showing 7201-7220 of 17342